Biotech

News

Ottimo Pharma chief executive David Epstein

Ottimo raises $140m for its PD-1/VEGF cancer drug

Ottimo raises $140m for PD-1 and VEGF-targeting jankistomig, which the startup says is differentiated from bispecific antibodies in the class.

News

Novo Holdings leads $100m round for novel painkiller biotech

SiteOne Therapeutics has completed a $100 million third-round financing that will support clinical trials of its non-opioid painkiller.

News

Atlas closes $450m biotech fund, and other financing news

Atlas Venture raised $450m for its fourteenth biotech round, while Nuvig, Maze, and Antag also closed financings this week.

R&D

Partner Content

Biotech Showcase marking 17 years of innovation and opportun...

Biotech Showcase is a cornerstone of the life science industry, with a 17-year history of connecting private and micro- to mid-cap biotech companies with top-tier investors and biopharmaceu

News

Adcendo raises $135m for cancer ADCs, and other financings

Adcendo raises $135m for cancer ADCs, plus financings for Enveda, Cradle Bio, ATB Therapeutics, and 35Pharma

News

Syncona aims Slingshot at biotech's 'translational gap'

UK-based life science investor Syncona has launched a new company – Slingshot Therapeutics – with a mission to find promising projects in academia and translate them into full-blown develop

Ottimo raises $140m for its PD-1/VEGF cancer drug

Novo Holdings leads $100m round for novel painkiller biotech

Atlas closes $450m biotech fund, and other financing news

Biotech Showcase marking 17 years of innovation and opportun...

Adcendo raises $135m for cancer ADCs, and other financings

Syncona aims Slingshot at biotech's 'translational gap'

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Biotech

Editor's Picks